The Experts below are selected from a list of 363 Experts worldwide ranked by ideXlab platform

Meliha C Kapetanovic - One of the best experts on this subject based on the ideXlab platform.

  • prevalence and incidence of non gout Crystal Arthropathy in southern sweden
    Arthritis Research & Therapy, 2019
    Co-Authors: Mohaned Hameed, Aleksandra Turkiewicz, Martin Englund, Lennart T H Jacobsson, Meliha C Kapetanovic
    Abstract:

    To estimate the prevalence and incidence of non-gout Crystal Arthropathy in relation to socioeconomic factors in southern Sweden. All patients (age ≥ 18 years) with at least one visit to a physician with the diagnosis of interest in the Skane region (population of 1.3 million) in 1998–2014 were identified. Non-gout Crystal Arthropathy (ICD-10 codes M11.0–M11.9) was subclassified in four different groups: calcium pyrophosphate Crystal deposition related Arthropathy (CPPD), unspecified non-gout arthropathies, chondrocalcinosis, and hydroxyapatite Crystal deposition disease. The crude and age-adjusted point prevalence on December 31, 2014, and the cumulative incidence during 2014 were calculated for all non-gout Crystal arthropathies, CPPD, and other unspecified non-gout arthropathies overall and in relation to occupation, income, and level of education. The crude 2014 point prevalence (95% CI) and 2014 cumulative incidence (95% CI) of all non-gout Crystal arthropathies were 0.23% (0.23–0.24) and 21.5 (19–25) cases/100,000 persons. Mean age (range) among all prevalent cases in 2014 was 71 (20–102) years and 56% were males. The point prevalence and cumulative incidence of CPPD were 0.09% (0.08–0.09) and 8 (7–10)/100,000 persons, respectively. The corresponding data for unspecified non-gout Crystal deposition disease was 0.16% (0.16–0.17) and 15.6 (13–18)/100,000 persons, respectively. The prevalence and incidence of CPPD and unspecified non-gout Crystal arthropathies were slightly higher in men and increased with age irrespective of gender. Unspecified non-gout Crystal Arthropathy but not CPPD was less prevalent in persons with ≥ 15 years of education, whereas there were no clear associations with occupation and income. The prevalence of all diagnosed non-gout Crystal arthropathies was 0.23%, thus considerably less prevalent than gout in southern Sweden. CPPD and other unspecified non-gout Crystal arthropathies are the predominant diagnoses, increasing with age and in men. With the exception for unspecified non-gout Crystal arthropathies being inversely correlated to a higher level of education, no convincing association with the socioeconomic factors was found.

  • thu0446 prevalence and incidence of non gout Crystal Arthropathy in southern sweden from the socioeconomic perspective
    Annals of the Rheumatic Diseases, 2017
    Co-Authors: Mohaned Hameed, Aleksandra Turkiewicz, Tore Saxne, L Jacobsson, Martin Englund, Meliha C Kapetanovic
    Abstract:

    Background Recently, we reported the prevalence of gout to be 1.7% among adults in the Skane region in southern Sweden (1). Few epidemiological data are available on non-gout Crystal Arthropathy and none for this region. Objectives The objective of this study was to study the prevalence and incidence of non-gout Crystal Arthropathy (including chondocalcinosis, acute/subacute/chronic calcium pyrophosphate/hydroxyapatite or other Crystal deposition disease) in southern Sweden from the socioeconomic perspective. Methods The Skane Healthcare Register includes information on all health care visits with given ICD10-coded diagnoses for all citizens in the region (total population 1.3 million). SHR was searched for all adult (≥18 years) residents in Skane region in year 2014, who between 1998 and 2014 had received at least one diagnosis of non-gout Crystal Arthropathy (ICD-10 code M11.0- M11.9) by any physician. The crude point prevalence at December 31st 2014 and the cumulative incidence in the calendar year 2014 were calculated. In addition, we examined the 2014 age- and sex- standardized point prevalence and cumulative incidence of non-gout Crystal Arthropathy according to occupation (white collar /blue collar with high or low skilled occupations), income (low/middle/high) and level of education (primary school/high school/university). Results The crude 2014 point prevalence and 2014 cumulative incidence (95% CI) of non-gout Crystal Arthropathy were 0.23% (0.22% - 0.24%) and 21.5 (18.6–24.3) cases per 100 000 persons at risk, respectively. Compared to women, men had numerically but not significantly higher prevalence (0.26% vs 0.20%) and incidence (24.6 vs 18.5 per 100 000 persons). This pattern remained regardless of age. The mean (SD) age of a person with prevalent non-gout Crystal Arthropathy was 71.5 (14.4) years. Both prevalence and incidence increased with increasing age and were highest in individuals ≥85 years (prevalence 1.4%), but decreased with years of education. Persons with middle income and blue collar high skilled occupation (e.g. skilled agricultural, forestry and fishery workers and craft and related trades workers) had the highest point prevalence and incidence of non-gout Crystal arthroplasty (figure). Conclusions Although considerably less prevalent than gout in southern Sweden non-gout Crystal Arthropathy affects about 0.2% of the adult population, i.e. a similar prevalence as for psoriatic arthritis in the same region. The prevalence increases with age and is highest among individuals aged 85 years or higher. There is a socioeconomic gradient with more affected individuals among people with lower level of education, middle income, and more manual work. References Kapetanovic MC, Hameed M, Turkiewicz A, at al. Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective. RMD Open. 2016 Nov 1;2(2):e000326. eCollection 2016. Disclosure of Interest None declared

Hyon K Choi - One of the best experts on this subject based on the ideXlab platform.

  • epidemiology of Crystal Arthropathy
    Rheumatic Diseases Clinics of North America, 2006
    Co-Authors: Hyon K Choi
    Abstract:

    Gout is an inflammatory arthritis mediated by the Crystallization of uric acid within the joints and often is associated with hyperuricemia. Data suggest that the overall disease burden of gout remains substantial and may be increasing. Identifying and characterizing modifiable risk factors for gout is a major step in preventing and managing this painful condition. As more scientific data on the risk factors and comorbidities of gout become available, their integration into gout prevention and care strategies may become essential. This article reviews the relevant epidemiologic data, with a focus on recent progress and data on other Crystal arthropathies.

Michael Doherty - One of the best experts on this subject based on the ideXlab platform.

  • Epidemiology of Calcium Pyrophosphate Crystal Arthritis and Basic Calcium Phosphate Crystal Arthropathy
    Rheumatic Diseases Clinics of North America, 2014
    Co-Authors: Abhishek Abhishek, Michael Doherty
    Abstract:

    Calcium pyrophosphate Crystal deposition (CPPD) is common and mainly associates with increasing age and osteoarthritis (OA). Recent studies suggest that CPPD occurs as the result of a generalized articular predisposition and may also associate with low cortical bone mineral density. The epidemiology of basic calcium phosphate (BCP) Crystal deposition is poorly understood. Although periarticular BCP Crystal deposits occurs at all ages and in both sexes, intra-articular BCP Crystal deposition tends to associate with increasing age and OA. Calcium pyrophosphate and BCP Crystals frequently coexist in joints with OA.

Martin Englund - One of the best experts on this subject based on the ideXlab platform.

  • prevalence and incidence of non gout Crystal Arthropathy in southern sweden
    Arthritis Research & Therapy, 2019
    Co-Authors: Mohaned Hameed, Aleksandra Turkiewicz, Martin Englund, Lennart T H Jacobsson, Meliha C Kapetanovic
    Abstract:

    To estimate the prevalence and incidence of non-gout Crystal Arthropathy in relation to socioeconomic factors in southern Sweden. All patients (age ≥ 18 years) with at least one visit to a physician with the diagnosis of interest in the Skane region (population of 1.3 million) in 1998–2014 were identified. Non-gout Crystal Arthropathy (ICD-10 codes M11.0–M11.9) was subclassified in four different groups: calcium pyrophosphate Crystal deposition related Arthropathy (CPPD), unspecified non-gout arthropathies, chondrocalcinosis, and hydroxyapatite Crystal deposition disease. The crude and age-adjusted point prevalence on December 31, 2014, and the cumulative incidence during 2014 were calculated for all non-gout Crystal arthropathies, CPPD, and other unspecified non-gout arthropathies overall and in relation to occupation, income, and level of education. The crude 2014 point prevalence (95% CI) and 2014 cumulative incidence (95% CI) of all non-gout Crystal arthropathies were 0.23% (0.23–0.24) and 21.5 (19–25) cases/100,000 persons. Mean age (range) among all prevalent cases in 2014 was 71 (20–102) years and 56% were males. The point prevalence and cumulative incidence of CPPD were 0.09% (0.08–0.09) and 8 (7–10)/100,000 persons, respectively. The corresponding data for unspecified non-gout Crystal deposition disease was 0.16% (0.16–0.17) and 15.6 (13–18)/100,000 persons, respectively. The prevalence and incidence of CPPD and unspecified non-gout Crystal arthropathies were slightly higher in men and increased with age irrespective of gender. Unspecified non-gout Crystal Arthropathy but not CPPD was less prevalent in persons with ≥ 15 years of education, whereas there were no clear associations with occupation and income. The prevalence of all diagnosed non-gout Crystal arthropathies was 0.23%, thus considerably less prevalent than gout in southern Sweden. CPPD and other unspecified non-gout Crystal arthropathies are the predominant diagnoses, increasing with age and in men. With the exception for unspecified non-gout Crystal arthropathies being inversely correlated to a higher level of education, no convincing association with the socioeconomic factors was found.

  • thu0446 prevalence and incidence of non gout Crystal Arthropathy in southern sweden from the socioeconomic perspective
    Annals of the Rheumatic Diseases, 2017
    Co-Authors: Mohaned Hameed, Aleksandra Turkiewicz, Tore Saxne, L Jacobsson, Martin Englund, Meliha C Kapetanovic
    Abstract:

    Background Recently, we reported the prevalence of gout to be 1.7% among adults in the Skane region in southern Sweden (1). Few epidemiological data are available on non-gout Crystal Arthropathy and none for this region. Objectives The objective of this study was to study the prevalence and incidence of non-gout Crystal Arthropathy (including chondocalcinosis, acute/subacute/chronic calcium pyrophosphate/hydroxyapatite or other Crystal deposition disease) in southern Sweden from the socioeconomic perspective. Methods The Skane Healthcare Register includes information on all health care visits with given ICD10-coded diagnoses for all citizens in the region (total population 1.3 million). SHR was searched for all adult (≥18 years) residents in Skane region in year 2014, who between 1998 and 2014 had received at least one diagnosis of non-gout Crystal Arthropathy (ICD-10 code M11.0- M11.9) by any physician. The crude point prevalence at December 31st 2014 and the cumulative incidence in the calendar year 2014 were calculated. In addition, we examined the 2014 age- and sex- standardized point prevalence and cumulative incidence of non-gout Crystal Arthropathy according to occupation (white collar /blue collar with high or low skilled occupations), income (low/middle/high) and level of education (primary school/high school/university). Results The crude 2014 point prevalence and 2014 cumulative incidence (95% CI) of non-gout Crystal Arthropathy were 0.23% (0.22% - 0.24%) and 21.5 (18.6–24.3) cases per 100 000 persons at risk, respectively. Compared to women, men had numerically but not significantly higher prevalence (0.26% vs 0.20%) and incidence (24.6 vs 18.5 per 100 000 persons). This pattern remained regardless of age. The mean (SD) age of a person with prevalent non-gout Crystal Arthropathy was 71.5 (14.4) years. Both prevalence and incidence increased with increasing age and were highest in individuals ≥85 years (prevalence 1.4%), but decreased with years of education. Persons with middle income and blue collar high skilled occupation (e.g. skilled agricultural, forestry and fishery workers and craft and related trades workers) had the highest point prevalence and incidence of non-gout Crystal arthroplasty (figure). Conclusions Although considerably less prevalent than gout in southern Sweden non-gout Crystal Arthropathy affects about 0.2% of the adult population, i.e. a similar prevalence as for psoriatic arthritis in the same region. The prevalence increases with age and is highest among individuals aged 85 years or higher. There is a socioeconomic gradient with more affected individuals among people with lower level of education, middle income, and more manual work. References Kapetanovic MC, Hameed M, Turkiewicz A, at al. Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective. RMD Open. 2016 Nov 1;2(2):e000326. eCollection 2016. Disclosure of Interest None declared

Mohaned Hameed - One of the best experts on this subject based on the ideXlab platform.

  • prevalence and incidence of non gout Crystal Arthropathy in southern sweden
    Arthritis Research & Therapy, 2019
    Co-Authors: Mohaned Hameed, Aleksandra Turkiewicz, Martin Englund, Lennart T H Jacobsson, Meliha C Kapetanovic
    Abstract:

    To estimate the prevalence and incidence of non-gout Crystal Arthropathy in relation to socioeconomic factors in southern Sweden. All patients (age ≥ 18 years) with at least one visit to a physician with the diagnosis of interest in the Skane region (population of 1.3 million) in 1998–2014 were identified. Non-gout Crystal Arthropathy (ICD-10 codes M11.0–M11.9) was subclassified in four different groups: calcium pyrophosphate Crystal deposition related Arthropathy (CPPD), unspecified non-gout arthropathies, chondrocalcinosis, and hydroxyapatite Crystal deposition disease. The crude and age-adjusted point prevalence on December 31, 2014, and the cumulative incidence during 2014 were calculated for all non-gout Crystal arthropathies, CPPD, and other unspecified non-gout arthropathies overall and in relation to occupation, income, and level of education. The crude 2014 point prevalence (95% CI) and 2014 cumulative incidence (95% CI) of all non-gout Crystal arthropathies were 0.23% (0.23–0.24) and 21.5 (19–25) cases/100,000 persons. Mean age (range) among all prevalent cases in 2014 was 71 (20–102) years and 56% were males. The point prevalence and cumulative incidence of CPPD were 0.09% (0.08–0.09) and 8 (7–10)/100,000 persons, respectively. The corresponding data for unspecified non-gout Crystal deposition disease was 0.16% (0.16–0.17) and 15.6 (13–18)/100,000 persons, respectively. The prevalence and incidence of CPPD and unspecified non-gout Crystal arthropathies were slightly higher in men and increased with age irrespective of gender. Unspecified non-gout Crystal Arthropathy but not CPPD was less prevalent in persons with ≥ 15 years of education, whereas there were no clear associations with occupation and income. The prevalence of all diagnosed non-gout Crystal arthropathies was 0.23%, thus considerably less prevalent than gout in southern Sweden. CPPD and other unspecified non-gout Crystal arthropathies are the predominant diagnoses, increasing with age and in men. With the exception for unspecified non-gout Crystal arthropathies being inversely correlated to a higher level of education, no convincing association with the socioeconomic factors was found.

  • thu0446 prevalence and incidence of non gout Crystal Arthropathy in southern sweden from the socioeconomic perspective
    Annals of the Rheumatic Diseases, 2017
    Co-Authors: Mohaned Hameed, Aleksandra Turkiewicz, Tore Saxne, L Jacobsson, Martin Englund, Meliha C Kapetanovic
    Abstract:

    Background Recently, we reported the prevalence of gout to be 1.7% among adults in the Skane region in southern Sweden (1). Few epidemiological data are available on non-gout Crystal Arthropathy and none for this region. Objectives The objective of this study was to study the prevalence and incidence of non-gout Crystal Arthropathy (including chondocalcinosis, acute/subacute/chronic calcium pyrophosphate/hydroxyapatite or other Crystal deposition disease) in southern Sweden from the socioeconomic perspective. Methods The Skane Healthcare Register includes information on all health care visits with given ICD10-coded diagnoses for all citizens in the region (total population 1.3 million). SHR was searched for all adult (≥18 years) residents in Skane region in year 2014, who between 1998 and 2014 had received at least one diagnosis of non-gout Crystal Arthropathy (ICD-10 code M11.0- M11.9) by any physician. The crude point prevalence at December 31st 2014 and the cumulative incidence in the calendar year 2014 were calculated. In addition, we examined the 2014 age- and sex- standardized point prevalence and cumulative incidence of non-gout Crystal Arthropathy according to occupation (white collar /blue collar with high or low skilled occupations), income (low/middle/high) and level of education (primary school/high school/university). Results The crude 2014 point prevalence and 2014 cumulative incidence (95% CI) of non-gout Crystal Arthropathy were 0.23% (0.22% - 0.24%) and 21.5 (18.6–24.3) cases per 100 000 persons at risk, respectively. Compared to women, men had numerically but not significantly higher prevalence (0.26% vs 0.20%) and incidence (24.6 vs 18.5 per 100 000 persons). This pattern remained regardless of age. The mean (SD) age of a person with prevalent non-gout Crystal Arthropathy was 71.5 (14.4) years. Both prevalence and incidence increased with increasing age and were highest in individuals ≥85 years (prevalence 1.4%), but decreased with years of education. Persons with middle income and blue collar high skilled occupation (e.g. skilled agricultural, forestry and fishery workers and craft and related trades workers) had the highest point prevalence and incidence of non-gout Crystal arthroplasty (figure). Conclusions Although considerably less prevalent than gout in southern Sweden non-gout Crystal Arthropathy affects about 0.2% of the adult population, i.e. a similar prevalence as for psoriatic arthritis in the same region. The prevalence increases with age and is highest among individuals aged 85 years or higher. There is a socioeconomic gradient with more affected individuals among people with lower level of education, middle income, and more manual work. References Kapetanovic MC, Hameed M, Turkiewicz A, at al. Prevalence and incidence of gout in southern Sweden from the socioeconomic perspective. RMD Open. 2016 Nov 1;2(2):e000326. eCollection 2016. Disclosure of Interest None declared